Small heat shock proteins have been the Cinderellas of the molecular chaperone world, but now the crystal structure of a small heat shock protein has been solved and mutation of two human homologues implicated in genetic disease. Intermediate filaments appear to be one of the key targets of their chaperone activity.
In recent years there has been intense interest in the molecular chaperones that assist protein folding, translocation and assembly inside cells. The best-known molecular chaperones were initially identified as heat shock proteins, which accumulate to a higher level in cells exposed to a heat shock and protect cells against stress. One large family of heat shock proteins has remained relatively poorly understood -these are the small heat shock proteins, a family of proteins with a molecular weight generally less than 30 kDa. Despite the relatively slow progress in elucidating how small heat shock proteins work, they have been implicated in many different cellular processes, such as the suppression of protein aggregation, cytoskeletal protein dynamics, cellular growth, transcription and differentiation. Of the six known human small heat shock proteins, some are widely expressed, whereas others are expressed in only one or two tissues. This difference in expression pattern suggests that small heat shock proteins may have general as well as specialised cellular functions.
Whatever the functions of small heat shock proteins might be, they are likely to involve at some level the regulation of protein-protein interaction. It is this chaperone-like property, arresting the heat-induced unfolding and aggregation of proteins [1] , which the scientific community has tended to focus on, testing possible physiological, as well as non-physiological substrates, in in vitro assays. More recently, evidence was obtained that small heat shock proteins might interact cooperatively with members of the heat shock protein 70 (Hsp70) family [2] . After a long history of research, two major advances have now been made in the small heat shock protein field: the first crystal structure of a small heat shock protein has been determined, and intermediate filaments have been identified as a physiological target of small heat shock proteins.
A comparison of small heat shock protein sequences from bacteria to man identified a highly conserved region, known as the α-crystallin domain because of its relationship to the lens protein of that name. The small heat shock protein Hsp16.5 from Methanococcus jannaschii consists almost entirely of an α-crystallin domain, and the crystal structure of this small heat shock protein has recently been determined [3] . This provides the first atomic-resolution view of this important domain; the remaining, amino-terminal 32 residues of the protein were disordered in the crystal, so their structure could not be determined and their role remains a matter of speculation, not only for this small heat shock protein, but also for the amino-terminal sequences of other small heat shock proteins.
In the crystal structure, Hsp16.5 was seen to form an oligomer of 24 subunits, indicating that the α-crystallin domain is involved in formation of multisubunit complexes. The α-crystallin domain of the lens protein αB-crystallin is also known to play a part in subunit-subunit binding [4] , though in this case additional amino-terminal sequences may be required for higher-order complex formation, suggesting that the α-crystallin domain alone may not be sufficient for oligomerisation of every small heat shock protein.
The high conservation of the α-crystallin domain in general, and certain residues in particular, should make it possible to model the structure of this part of other small heat shock proteins. Such models should not only fire the enthusiasm of those in the field, but also direct the analysis of mutations to study their structure and chaperone activities.
The importance of particular residues within the α-crystallin domain has been demonstrated by recent genetic evidence that mutations in two human homologues of Hsp16.5, αA-crystallin and αB-crystallin, are responsible for genetic disorders. In αA-crystallin, substitution of arginine 116 by cysteine was found to be the cause of autosomal dominant congenital cataract [5] . And in αB-crystallin, substitution of arginine 120 by glycine (R120G) was found to be the cause of another autosomal dominant disease, desmin-related myopathy [6] . Both of these small heat shock proteins are very abundantly expressed in the eye lens, and indeed the αB-crystallin mutation also caused cataracts. But whereas αA-crystallin is specifically expressed in the eye lens, αB-crystallin is also expressed in many other tissues and is particularly abundant in muscle. Although the mutations involve two separate small heat shock proteins, they both affect the same conserved arginine in the α-crystallin domain, equivalent to arginine 107 in M. jannaschii Hsp16.5.
In the Hsp16.5 crystal structure [3] , arginine 107 is seen to play an unusual role, as it is highly charged yet largely buried in the hydrophobic protein core, instead of being exposed on the surface of the β sheet (Figure 1a,b) . It appears that the position of the arginine 107 side chain is rigidly defined within the structure. The aliphatic side chain has the hydrophobic properties required for accommodation in the local environment of the protein core. The charged guanidinium group, however, forms a bifurcated hydrogen bond with the carbonyl oxygen of glycine 41 in the backbone of the loop between β1 and β2 (Figure 1a,b) and is about 50% accessible on the subunit surface (Figure 1c) . The major effect of these interactions is that the placing of arginine 107 in the structure is highly constrained, adding to the internal 'glue' of the β sheet arrangement and certainly determining the position of the β1-β2 loop. This would make the arginine an ideal contributor to substrate binding, as little entropy would be lost upon binding.
In the Hsp16.5 structure, arginine 107 is not directly involved in subunit-subunit interactions within the 24-subunit oligomer [3] . This conclusion is supported by the observation that this residue was not mutated in any of a series of αB-crystallin mutants that cannot assemble into oligomers, and even when the R120G mutation was introduced it did not disrupt subunit-subunit binding in a yeast two-hybrid assay [4] . Whether this arginine is directly involved in substrate binding, or whether it stabilises the protein structure and in this way influences the protein's putative chaperone activity, remains to be experimentally verified. Nevertheless, combining structural details on the conserved arginine with information on diseases caused by its mutation should illuminate the aetiology of the diseases and the cellular role and target of small heat shock proteins.
The genetic results show that the conserved arginine plays a very important role in the function of small heat shock proteins. It also indicates where in the body these small heat shock proteins have an essential function. The correlation of the αA-crystallin mutation with the cataract phenotype confirms a key role for αA-crystallin in the lens. This had already been strongly suggested by the analysis of mice lacking αA-crystallin, which developed cataract and showed inclusion bodies containing αB-crystallin in their lenses [7] . The analogy even goes further in that patients with the αA-crystallin mutation, like the αA-crystallin knock-out mice, suffer from microphthalmia, suggesting that αA-crystallin might have a role in eye development. Although αB-crystallin is much more widely expressed, the genetic results are consistent with the view that its function is most prominent in those tissues where it is expressed at the highest level: cardiac and skeletal muscle and the lens.
Perhaps the most interesting feature of the genetic data is that now something important can be learnt about the physiological substrates of small heat shock proteins. Unfortunately, no detailed information is available about the way in which cataracts are formed in families carrying αA-crystallin mutations, but luckily more information is available from myopathy patients carrying the αB-crystallin R104 Current Biology, Vol 9 No 3 Figure 1 (a,b) Two views of the monomer structure of Hsp16.5 from Methanococcus jannaschii are shown with the backbone in orange (graphics generated using software InsightII, MSI). The important residue arginine 107 is highlighted in magenta, and the β1-β2 loop is green. Note that the arginine 107 side chain is directed inwards from the β sheet towards the hydrophobic core of the protein (a), but that the charged end group reaches the surface by pointing sideways to the edge of the sheet (b). The bifurcated hydrogen bonds between the charged guanidinium group of arginine 107 and the carbonyl oxygen of glycine 41 are represented by the dotted lines. (c) The solvent accessible surface of an Hsp16.5 subunit, calculated using GRASP [13] . Arginine 107 is highlighted in magenta and the β1-β2 loop is green, showing that about half of the arginine charged end group is accessible on the surface. [10, 11] and the aggregates most certainly contain small heat shock proteins, as is found to be the case in many desmin-related pathologies [6, 12] . These associated small heat shock proteins cannot prevent intermediate filament aggregate formation, as similar disease phenotypes result from both desmin and αB-crystallin mutations. These results clearly identify intermediate filaments as a physiological target for the chaperone activity of the small heat shock proteins.
